{"issuance_frequency":"","notes_translated":{"fr":"Pendant la pandémie, il pourrait y avoir d’autres écarts par rapport au protocole établi. Malgré cela, il est important de continuer à protéger la sécurité des patients et à veille à l’intégrité des données. Le présent avis aborde les préoccupations des promoteurs d’essais cliniques et des Canadiens.","en":"During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity. This notice addresses the concerns of clinical trial sponsors and Canadians."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"1a07e49c-198a-4ce1-a645-d67de65cc8a5","metadata_created":"2021-05-28T15:11:06.107308","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-05-28T15:11:06.107314","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-05-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","pandémie","gestion des essais cliniques","avis aux promoteurs d'essais cliniques","protocole établi","sécurité des patients","intégrité des données"],"en":["COVID-19","pandemic","management of clinical trials","notice to clinical trial sponsors","established protocol","patient safety","data integrity"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"1a07e49c-198a-4ce1-a645-d67de65cc8a5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"950f8897-7338-45e4-b109-57ec68ad7b89","related_relationship":"","name_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","language":["en"],"created":"2021-05-28T15:11:06.184693","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/management-clinical-trials-during-covid-19-pandemic.html","last_modified":null,"position":0,"revision_id":"13e1d40c-4bdc-4799-b7e1-3e5e6c7f4490","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"1a07e49c-198a-4ce1-a645-d67de65cc8a5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f48654b8-3469-48df-a8f6-edccf4fdbb48","related_relationship":"","name_translated":{"fr":"La gestion des essais cliniques pendant la pandémie de COVID-19 : Avis aux promoteurs d’essais cliniques","en":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","language":["fr"],"created":"2021-05-28T15:11:06.184699","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/gestion-essai-clinique-pendant-pandemie-covid-19.html","last_modified":null,"position":1,"revision_id":"13e1d40c-4bdc-4799-b7e1-3e5e6c7f4490","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-05-06 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"1a07e49c-198a-4ce1-a645-d67de65cc8a5","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect patient safety and ensure data integrity. This notice addresses the concerns of clinical trial sponsors and Canadians.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors","revision_id":"13e1d40c-4bdc-4799-b7e1-3e5e6c7f4490"}